These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28121622)

  • 1. The Tat-Aβ1-6A2V(D) peptide against AD synaptopathy.
    Buccarello L; Borsello T
    Oncotarget; 2017 Feb; 8(7):10773-10774. PubMed ID: 28121622
    [No Abstract]   [Full Text] [Related]  

  • 2. The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt.
    Cimini S; Sclip A; Mancini S; Colombo L; Messa M; Cagnotto A; Di Fede G; Tagliavini F; Salmona M; Borsello T
    Neurobiol Dis; 2016 May; 89():101-11. PubMed ID: 26721320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presenilin-1 Targeted Morpholino Induces Cognitive Deficits, Increased Brain Aβ
    Nery LR; Silva NE; Fonseca R; Vianna MRM
    Neurochem Res; 2017 Oct; 42(10):2959-2967. PubMed ID: 28623607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease.
    Xu L; Ren Z; Chow FE; Tsai R; Liu T; Rizzolio F; Boffo S; Xu Y; Huang S; Lippa CF; Gong Y
    Neural Plast; 2017; 2017():3270725. PubMed ID: 28458925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation.
    Mondragón-Rodríguez S; Trillaud-Doppia E; Dudilot A; Bourgeois C; Lauzon M; Leclerc N; Boehm J
    J Biol Chem; 2012 Sep; 287(38):32040-53. PubMed ID: 22833681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
    Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
    Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
    Andriuta D; Moullart V; Schraen S; Devendeville A; Meyer ME; Godefroy O;
    J Alzheimers Dis; 2016; 51(3):793-800. PubMed ID: 26923012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
    Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
    Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of NMDA receptors in Alzheimer's disease.
    Zhang Y; Li P; Feng J; Wu M
    Neurol Sci; 2016 Jul; 37(7):1039-47. PubMed ID: 26971324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease.
    García-Font N; Hayour H; Belfaitah A; Pedraz J; Moraleda I; Iriepa I; Bouraiou A; Chioua M; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Aug; 118():178-92. PubMed ID: 27128182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-activation of VEGF and NMDA receptors promotes synaptic targeting of AMPA receptors.
    De Rossi P; Harde E; Dupuis JP; Martin L; Chounlamountri N; Bardin M; Watrin C; Benetollo C; Pernet-Gallay K; Luhmann HJ; Honnorat J; Malleret G; Groc L; Acker-Palmer A; Salin PA; Meissirel C
    Mol Psychiatry; 2016 Dec; 21(12):1647. PubMed ID: 27847390
    [No Abstract]   [Full Text] [Related]  

  • 14. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
    Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
    Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APP depletion alters selective pre- and post-synaptic proteins.
    Martinsson I; Capetillo-Zarate E; Faideau M; Willén K; Esteras N; Frykman S; Tjernberg LO; Gouras GK
    Mol Cell Neurosci; 2019 Mar; 95():86-95. PubMed ID: 30763689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of PTEN attenuates cognitive deficits caused by neonatal repeated exposures to isoflurane via inhibition of NR2B-mediated tau phosphorylation in rats.
    Tan L; Chen X; Wang W; Zhang J; Li S; Zhao Y; Wang J; Luo A
    Neuropharmacology; 2017 Mar; 114():135-145. PubMed ID: 27836791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β.
    Di Fede G; Catania M; Maderna E; Morbin M; Moda F; Colombo L; Rossi A; Cagnotto A; Virgilio T; Palamara L; Ruggerone M; Giaccone G; Campagnani I; Costanza M; Pedotti R; Salvalaglio M; Salmona M; Tagliavini F
    Sci Rep; 2016 Feb; 6():20949. PubMed ID: 26864599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.
    Blanchard BJ; Chen A; Rozeboom LM; Stafford KA; Weigele P; Ingram VM
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14326-32. PubMed ID: 15388848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.